Full Press Release Details
PALO ALTO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences:
Citi’s 17th Annual BioPharma Conference, Boston, MA: September 7th at 8:50 am ET
Morgan Stanley Global Healthcare Conference, New York, NY: September 13th at 7:20 am ET
Baird Global Healthcare Conference, New York, NY: September 14th at 12:50 pm ET
H.C. Wainwright 24th Annual Global Investment Conference, New York, NY: September 14th at 11:30 am ET
Cantor Fitzgerald’s Genetic Medicines Conference, New York, NY: September 15th
Jefferies Genetic Cell and Medicine Summit, New York, NY: September 29th
Biotech South Beach, Miami, FL: September 29th
To access the live webcast of BridgeBio’s presentations, please visit the “Events” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.